The promyelocytic HL60 cell can be differentiated with dimethyl sulphoxide or dibutyryl cyclic AMP leading to the appearance of fMetLeuPhe receptors on the cell surface. G-protein-stimulated polyphosphoinositide phosphodiesterase (PPI-pde) activity was assessed in membranes prepared from both differentiated and non-differentiated HL60 cells. Both the extent of the response and the rank order of potency of the GTP analogues to stimulate PPI- 
INTRODUCTION
Ca2l-mobilizing receptors activate polyphosphoinositide phosphodiesterase (PPI-pde), generating two intracellular second messengers, IP3 (inositol trisphosphate) and diacylglycerol [1, 2] . There is accumulating evidence that activation of membranebound PPI-pde is coupled to receptors via a putative guanine nucleotide binding protein, Gp [3] [4] [5] . PPI-pde activation in many cell types can be stimulated by nonhydrolysable analogues of GTP and by fluoride, indicating the common features shared with other G-protein-mediated signalling systems [6, 7] .
In order to understand the individual components that make up the inositide signalling system, we have studied the effect of two potential inhibitors of PPI-pde activity. Pretreatment with pertussis toxin blocks agonistmediated stimulation of PPI-pde activity in some types of cells, but not in others [3, 4] . The effects of pertussis toxin on Gj, Go and transducin are known to cause ADPribosylation ofa cysteine residue ofthe G-protein, leading to the uncoupling of the receptor from the G-protein while leaving responses to GTP [S] or fluoride intact [8] [9] [10] [11] . We would thus predict that pertussis-toxin pretreatment would inhibit receptor-stimulated PPI-pde without affecting PPI-pde stimulation by fluoride or GTP [S] . Contrary to the above prediction, it has been reported that GTP[S]-stimulated PPI-pde activity in rabbit neutrophils [12] and fluoride-stimulated PPI-pde activity in hamster fibroblasts [13] can be inhibited by pertussis-toxin pretreatment. We have examined the effect of pertussis-toxin pretreatment of HL60 cells on PPI-pde activity, and find that only the receptorstimulated PPI-pde activity is blocked similarly to the other G-protein-mediated signalling systems. Neomycin has been frequently used as an inhibitor of PPI-pde activity stimulated either directly by millimolar concentrations of Ca2l or indirectly by guanine nucleotides [14] [15] [16] [17] . This effect of neomycin has been exploited to study the relevance of the inositide signalling pathway in cellular processes [17] [18] [19] . In a recent study on streptolysin-O-permeabilized mast cells, we used neomycin to dissociate GTP[S]-stimulated PPI-pde activity from GTP[S]-stimulated secretion, which led us to conclude that the secretory response is under the control of a second G-protein, GE [17] . Since secretion from HL60 cells also appears to be under the control of a second G-protein [20] , we have analysed the effects of neomycin on PPI-pde activity and on exocytosis.
METHODS AND MATERIALS

Materials
Pertussis toxin was obtained from Porton Products, CAMR, Porton Down, Salisbury, Wilts., U.K., and bovine serum albumin (Pathocyte IV) from ICN Bio-medicals, High Wycombe, Bucks., U.K. The sources of all other materials were as described previously [20] .
Methods
Culturing and labelling of HL60 cells. HL60 cells were maintained in culture and labelled with [3H]inositol as described previously [20] , except that Medium 199 was routinely supplemented with bovine serum albumin (3.5 mg/ml).
Differentiation of HL60 cells. HL60 cells were differentiated with either DMSO [21, 22] or dibutyryl cyclic AMP [23] towards a neutrophil-like cell. The cells were incubated with 1.3 % (v/v) DMSO for 3 days and then transferred to the labelling medium with 1 % DMSO for a further 2 days. When dibutyryl cyclic AMP was used as the differentiating agent, it was added at 300 /M for 40 h to the labelling medium. In both cases the appearance of receptors for fMetLeuPhe were monitored by measurement of fMetLeuPhe-induced secretion of fl-glucuronidase in intact cells.
Preparation and activation of membranes. Membranes were prepared at 4 'C. The cells (2 x 108-3 x 108) were washed three times in a buffered salt solution (pH 7.2), which contained 137 mM-NaCl, 2.7 mM-KCl and 20 mMHepes, and finally suspended in buffer (pH 7.2) consisting of 250 mM-sucrose, 20 mM-Hepes and 100 /,M-EGTA.
The cells were disrupted by sonication for 10 s with an MSE probe, and the homogenate was centrifuged at 600 g for 5 min to remove any intact cells. The resulting homogenate was diluted with buffer (20 mM-Pipes/ 150 mM-KCl, pH 6.8; termed 'Pipes/K buffer') to 40 ml and centrifuged at 35 000 rev./min (86 500 gav) for 20 min to pellet the membranes.
The pellet was resuspended in the Pipes/K buffer at a protein concentration of 1-2 mg/ml. The Pipes/K buffer was supplemented with MgATP (2 mm final concn.), Ca2l buffered with EGTA at the required pCa (as indicated in the Figures), MgCl2 (2 mm final concn.), LiCl (10 mm final concn.) and 2,3-bisphosphoglycerate (2 mm final concn.). Ca21 was buffered with 3 mM-EGTA as described previously [24] . The concentration of the supplements was twice the final concentration at this stage. Portions (100 ,l) of membranes were dispensed into glass tubes which contained an equal volume of buffer supplemented with the various additions as indicated in the individual Figures. The membranes were incubated for 10 min at 37 'C. In experiments where the Ca2+ concentration was varied (Fig. 2) , the Ca2' buffer was not added to the membranes, but was added directly to the tubes.
When fluoride or millimolar Ca2+ was used as an activator, Ca2+-EGTA buffers were excluded, because activation by fluoride is dependent on the presence of Al3+ [25, 26] , which would be chelated by EGTA. In this case the concentration of free Ca21 was approx. 1-5 /M, owing to the presence of contaminating Ca21 [27] .
Incubations were terminated by addition of chloroform/methanol (1:2, v/v), and the aqueous top phase was used for the analysis of inositol phosphates by ionexchange chromatography on Dowex columns as described previously [17] . It was observed that most of the changes were mainly confined to TP3, and to a lesser extent to IP2 (see Fig. 2 ), with very little change in IP1.
In many experiments the 1P2 and IP3 fractions were collected together unless specified otherwise. The bottom chloroform phase, which contained the lipids, was dried down, and total radioactivity (d.p.m.) used per incubation was determined where required.
Cell permeabilization and stimulation. Cells were permeabilized with streptolysin 0 as described previously [20] . In brief, cells were permeabilized with 0.4 i.u. of streptolysin O/ml in a buffered salt solution (pH 6.8) which contained 137 mM-NaCl, 2.7 mM-KCI, 20 mmPipes, 5.6 mM-glucose, 1 mg of albumin/ml, Ca2l buffered with 3 mM-EGTA (pCa 7 or pCa 5 as indicated in Figure legends) , 2 mM-MgATP, 2 mM-MgCl2 and 10 mM-LiCl. Other additions, such as guanine nucleotides, were made as indicated in the Figure legends. After 10 min at 37°C, the cells were sedimented at 600 g for 5 min, and 50 ,ul of the supernatant was retained for the measurement of ,?-glucuronidase secretion as described previously [28] . The rest of the incubation was quenched with chloroform/methanol and processed as above. In permeabilized cells increases in all three inositol phosphates are observed [20] Measurement of secretion and inositol phosphate formation stimulated by fMetLeuPhe in intact HL60 cells. Differentiated HL60 cells were washed three times and finally resuspended in a buffered salt solution (pH 7.4) containing 20 mM-Hepes, 137 mM-NaCl, 2.7 mM-KCI, 1 mM-CaCl2, 10 mM-LiCl, 5.6 mM-glucose and 1 mg of albumin/ml. The cells were pretreated with cytochalasin B [28] and transferred into tubes containing fMetLeuPhe for 10 min at 37 'C. Secretion and inositol phosphate formation were measured as described above.
Pretreatment with pertussis toxin. Pretreatment of cells with pertussis toxin (500 ng/ml) was carried out in Medium 199 with the cells concentrated to 10'/ml for 2 h at 37 'C.
Expression of data. All determinations were carried out in duplicate. In some experiments the increase in inositol phosphates is expressed as a function of the total radioactivity (d.p.m.) incorporated in the inositol lipids. This allowed us to calculate the percentage hydrolysis of the total inositol lipids in individual experiments, so that comparison could be made between membranes and permeabilized cells.
RESULTS AND DISCUSSION
Comparison of PPI-pde activity in differentiated and non-differentiated HL60 cells
The HL60 cell is a promyelocytic cell line which can be terminally differentiated into a neutrophil-like cell by inducers such as DMSO and dibutyryl cyclic AMP. Upon differentiation, receptors for agonists such as fMetLeuPhe are expressed [22, 23] . We by three different analogues of GTP in membranes prepared from DMSO-differentiated and undifferentiated cells. The concentration of DMSO used here gives maximum induction of maturation without inhibition of cell growth [21, 29] (3) 0.37+0.16 (9) fluoride in differentiated HL60 cells compared with nondifferentiated cells. PPI-pde activity can also be activated directly by millimolar concentrations of Ca2l [32] , and we have utilized this response to assess the effect of differentiation on the catalytic activity itself. Table 1 shows that the response to millimolar concentrations of Ca2" is hardly affected. We have consistently observed that millimolar concentrations of Ca2l are less active in stimulating production of IP2 plus 1P3 compared with GTP[S] or fluoride (see Table 1 and Fig. 6a ). Differentiation of HL60 cells with DMSO or dibutyryl cyclic AMP leads to an increase in the major pertussistoxin substrate as assessed by immunochemical analysis. The increase is only apparent when the results are expressed as ,ug of HL60-membrane protein, but not when expressed on a cell-equivalent basis [33, 34] . This difference is most likely due to the decrease in size that occurs upon differentiation [21, 29] . The major pertussistoxin substrate (40 kDa) of neutrophils and HL60 cells is structurally different from all previously described pertussis-toxin substrates [35, 36] . Since receptorstimulated PPI-pde activation is pertussis-toxin-sensitive in these cells [37, 38 ; also see below], the pertussis-toxin substrate in these cells may be the putative Gp.
At a functional level, the process of differentiation with DMSO or dibutyryl cyclic AMP leads to no change or a 50 % decrease respectively in PPI-pde activity. Thus the increase in the G-protein observed on a protein basis does not appear to be reflected on a functional level. cells, Ca2l is necessary to observe maxima receptor-directed agonists [4] . We have the the Ca2l-dependence of the HL60 mem activity. Ca2" alone can stimulate PPI-pd increased from 100 nm to 10 gM, the relevant range, but this increase is relativ 2). In the experiment presented in Fig. 2 , tl (d.p.m.) in IP3 at pCa 7 is 203, compar( pCa 5. Ca2l only becomes very effective centration is raised above 100 /M (Fig. 2) . of GTP[S], the Ca2l requirement is sh concentrations, such that maximal IP3 observed at pCa 5. The stimulation of P by Ca2" is analogous to the activatior cyclase by forskolin, in that both can activE unit without the intervention of the G-p However, the affinity for forskolin is incre that stimulate G. [41] , similarly to the ir affinity when Gp is activated.
The Ca2l-sensitivity of the G-proteinpde observed in membranes has also beer in permeabilized and intact HL60 cells [ (Fig. 2) . The different Ca2+-sensiti in cells compared with membranes may be related to separate activities of PPI-pde (see below).
Three distinct effects of Ca2" can be discerned. (1) Ca2" alone can stimulate PPI-pde activity to a minor extent when its concentration is increased in the physiologically relevant range, i.e. 100 nm raised to 1O lUM, and to a greater extent at millimolar concentrations. (2) Ca2" is required in the nanomolar range for activation by GTP [S] . (3) Ca2" potentiates the GTP[S]-stimulated PPIpde activity when its concentration is increased in the physiologically relevant range. One consequence of Ca2+-induced potentiation is that in intact cells the receptormediated increase in cytosolic Ca21 will activate the production of IP3. This amplification of the Ca2" signal may provide the fine control for the generation of Ca2" transients [43] . Effect of pertussis toxin on G-protein-regulated PPI-pde Pertussis-toxin pretreatment of HL60 cells leads to inhibition of both the functional response (i.e. secretion) and inositol phosphate production when differentiated HL60 cells are stimulated with fMetLeuPhe ( Figs. 3a and  3b) . Similar inhibition offMetLeuPhe-stimulated inositol phosphate formation is observed in streptolysin-Opermeabilized cells [4] . In contrast, stimulation of PPI-5 4 3 pde by GTP[S] either in membranes or in permeabilized HL60 cells is not inhibited when the cells are pretreated with pertussis toxin (Fig. 4) [7, 9] . [8, 10, 11] . We show here that the activation of PPI-pde by lifted to lower the receptor is blocked in pertussis-toxin-pretreated cells production is (Fig. 3 ), but this does not affect the activation of PPI-pde 'PI-pde activity when stimulated directly by GTP[S] (Fig. 4) or fluoride i of adenylate (Fig. 5 ). This situation is analogous to the characteristics ate the catalytic known for the other G-proteins, and also implies that rotein [39] [40] [41] .
Gp may possess the same cysteine residue. Effect of neomycin on PPI-pde activity and on secretion Neomycin has been widely used as an inhibitor of PPI- pde activity, and the mechanism of neomycin-mediated inhibition is understood to depend on its ability to bind phosphatidylinositol bisphosphate and, to a lesser extent, phosphatidylinositol monophosphate [14, 17, 47] . This would mean that neomycin should inhibit PPI-pde activity regardless of its mode of activation. Fig. 6(a) illustrates the inhibition of IP3 production by neomycin However, 1 mM-neomycin only partially inhibits the response caused by fluoride, and complete inhibition is observed at 3 mm (Fig. 6a) . This would imply that neomycin is not acting solely at the level of substrate sequestration.
In order to test whether we could use neomycin to block PPI-pde activity selectively while leaving secretion intact as in mast cells [17] , we have measured the concentration-dependence of neomycin-mediated inhibition for both processes in permeabilized HL60 cells. Neomycin inhibits the two processes with a similar dependence, with secretion being slightly less sensitive than IP3 production (Fig. 6b) . The mechanism by which neomycin inhibits secretion in permeabilized HL60 cells is not clear, but it is unlikely to be due to inhibition of IP3 formation, since secretion (in the presence of pCa 5) can be independent of PPI-pde activity [20] . Since the effects of neomycin are not confined to inhibition of PPIpde activity, any inhibition by neomycin of a particular process cannot always be attributed to inhibition of PPIpde activity.
In our study on mast cells, neomycin blocked IP3 production at 300 /SM, while leaving secretion intact. Neomycin will block secretion in mast cells when its concentration is raised to millimolar (B. D. Gomperts, unpublished work). Thus the secretory mechanisms of the two cell types are not fundamentally different in their response to neomycin. In HL60 cells, the concentrationdependences for neomycin inhibition of secretion and IP3 production happen to be similar, whereas in mast cells there is a region where secretion is relatively unaffected while PPI-pde activity is totally blocked. Comparison of the extent of PPI-pde stimulation observed in membranes and in permeabilized cells
We have observed that the degree of stimulation of PPI-pde activity in membranes compared with permeabilized undifferentiated HL60 cells is different. This became apparent when we expressed our data as percentage hydrolysis (i.e. d.p.m. observed in inositol phosphates as a percentage of the total radioactivity incorporated in the inositol lipids). Fig. 4 illustrates the results from an experiment where we have compared membranes with permeabilized cells. The percentage hydrolysis stimulated with GTP[S] in permeabilized cells is approx. 10-fold greater than in membrane preparations (Fig. 4) . We have also summarized our results for all our experiments, and find that the mean maximum percentage hydrolysis stimulated by GTP[S] at pCa 7 obtained in membranes is 0.72+0.27 (mean+s.D., n = 12), in contrast with 3.56+0.97 (n = 13) in permeabilized cells.
It is well established that there is inositol-lipidhydrolysing activity in the cytosol which consists of multiple forms of enzymes based on molecular mass and comparison of the catalytic and immunologic properties [48] [49] [50] [51] [52] . The presence of this activity in permeabilized cells may account for the differences that we observe. Although permeabilization with streptolysin 0 generates lesions such that lactate dehydrogenase is released to the extracellular medium [20] , it is possible that the cytosolic inositol-lipid-hydrolysing activity is still retained in these permeabilized cells, i.e. that this activity may not be truly cytosolic. The observation that the Ca2'-sensitivity of the PPI-pde activity in membranes is different from that seen in permeabilized cells further supports the notion that multiple activities are involved [20] . In preliminary studies, we have been able to restore the GTP[S]-stimulated extent of hydrolysis in membranes to that observed in permeabilized cells by addition of cytosol prepared from pig lymphocytes to HL60 membranes [4] . Thus, in order to study the regulation of IP3 production, it may be necessary not only to study the membranebound form of PPI-pde activity but also the cytosolic activity. It is clear that the permeabilized cell preparation is a more complete model for studying the inositide signalling system, rather than utilizing membranes.
